Skip to main content
. 2021 Aug 1;25(8):655–661. doi: 10.5588/ijtld.21.0170

Table 1.

Patient characteristics

Baseline characteristics All patients (n = 163) n (%) Any vDOT (n = 94) n (%) No vDOT* (n = 69) n (%) P value
Age, years, mean ± SD 52.3 ± 19.7 46.1 ± 17.7 60.8 ± 19.3 <0.001
Female sex 63 (38.7) 41 (43.6) 22 (31.9) 0.129
Foreign-born 152 (93.3) 88 (93.6) 64 (92.8) 0.828
Ethnicity Hispanic 22 (13.5) 15 (16.0) 7 (10.1) 0.377
Race 0.148
 Asian 121 (74.2) 65 (69.1) 56 (81.2)
 Native Hawaiian/Other Pacific Islander 6 (3.7) 5 (5.3) 1 (1.4)
 Black/African American 11 (6.7) 5 (5.3) 6 (8.7)
 White 19 (11.7) 15 (16.0) 4 (5.8)
 Unknown/not reported 6 (3.7) 4 (4.3) 2 (2.9)
Limited or no English 75 (46) 39 (41.5) 36 (52.2) 0.149
Occupation 0.056
 Health care worker 9 (5.5) 6 (6.4) 3 (4.3)
 Other worker 74 (45.4) 51 (54.3) 23 (33.3)
 Not seeking employment 62 (38.0) 29 (30.9) 33 (47.8)
 Unemployed 13 (8.0) 5 (5.3) 8 (11.6)
 Unknown 4 (2.5) 2 (2.1) 2 (2.9)
Homelessness 4 (2.5) 2 (2.1) 2 (2.9) 0.753
Married/domestic partnership 102 (62.6) 59 (62.8) 43 (62.3) 0.954
Children in household 76 (46.6) 41 (43.6) 35 (50.7) 0.267
HIV-infected 5 (3.1) 4 (4.4) 1 (1.4) 0.019
Any drug use 5 (3.1) 3 (3.2) 2 (2.9) 0.688
Any alcohol use 2 (1.2) 2 (2.1) 0 (0.0) 0.099
Diabetes 49 (30.1) 24 (25.5) 25 (36.2) 0.759
TB drug resistance 22 (13.5) 12 (12.8) 10 (14.5) 0.926
AFB smear result 59 (36.2) 33 (35.1) 26 (37.7) 0.360
Any immunosuppression 12 (7.4) 8 (8.5) 4 (5.8) 0.512
*

No vDOT represents a combination of patients with self-administered and in-person DOT.

Age as of TB treatment start date.

Statistically significant.

vDOT = video directly observed therapy; SD = standard deviation; AFB = acid-fast bacilli.